长期COVID的全球临床研究
Diego Ramonfaur1, Nardeen Ayad2, Peter Hong Zhi Liu3
1Cleveland Clinic, Cleveland, Ohio, United States.
概括
长期COVID是SARS-CoV-2感染后的一种持续性疾病,影响全球数百万人. 目前的临床试验探讨了各种治疗方法,但很少有确定的结果,这凸显了进一步研究的必要性.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 长期COVID呈现SARS-CoV-2感染后持续症状,区域发病率各不相同.
- 越来越多的病例挑战了医疗保健系统,但治疗指南仍然有限.
- 政府资助的倡议正在增加,推动长期COVID治疗的临床试验.
研究的目的:
- 分析正在进行的临床试验的情况,调查长期COVID的治疗方法.
- 为了确定试验地点,干预措施和向症状的趋势.
- 突出当前研究的差距,例如睡眠障碍和潜在的病理生理学的不足.
主要方法:
- 对世界卫生组织国际临床试验注册平台进行了系统的搜索.
- 确定了与长期COVID相关的587项临床研究.
- 312项专注于潜在疗法的研究进一步分析了干预措施,位置和向症状.
主要成果:
- 超过一半的长期COVID研究 (312/587) 正在测试疗法.
- 美国,印度和西班牙在审判行为方面处于领先地位.
- 干预措施的范围从运动和行为疗法到药理学药物,如Paxlovid和fluvoxamine.
- 发表的治疗试验结果有限,并且基本上没有确定性 (11/312).
结论:
- 目前正在进行大量的长期COVID临床试验,探索各种治疗方法.
- 目前的研究已经产生了有限的确认结果,需要进一步调查.
- 未来的研究应该包括睡眠障碍治疗,并针对长期COVID的潜在病理生理学.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Long-term Depression
30.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.8K
COPD: Pathogenesis and Clinical Features
259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


